Diagnostic utility of MOC-31, HBME-1 and MOC-31mRNA in distinguishing between carcinoma cells and reactive mesothelial cells in pleural effusions

Acta Cytologica

Volumn 53, Issue 6, 2009, Pages 619-624

  Sun, Ying ^a   Wu, Guang Ping ^a   Fang, Chang Qing ^a   Liu, Shu Li ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Immunocytochemistry; Lung cancer; Pleural effusion; Reverse transcriptase polymerase chain reaction

Indexed keywords

MESSENGER RNA; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY HBME 1; MONOCLONAL ANTIBODY MOC 31; TUMOR MARKER; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ARTICLE; CANCER DIAGNOSIS; CARCINOMA CELL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE MARKER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MESOTHELIUM CELL; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 73949151194     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000325401     Document Type: Article

References (20)

1. Monte SA, Ehya H, Lang WR: Positive effusion cytology as the initial presentation of malignancy. Acta Cytol 1987 ;31:448-152
2. Mnskell NA, Butland RJA: BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax (suppl 11) 2003;58:ii8-ii7
3. Ordoñez NG: Value of immunohistochemistry in distinguishing peritoneal mesothelioma from serous carcinoma of the ovary and peritoneum: A review and update. Adv Anat Pathol 2006;13:16-25
4. Oates J, Edwards C: HBME-1, MOC-31, WT1 and calretinin: An assessment of recently described markers for mesothelioma and adenocarcinoma. Histopathology 2000;36:341-347
5. Politi E, Kandaraki C, Apostolopoulou C, Kyritsi T, Koutselini H: Immunocytochemical panel for distinguishing between carcinoma and reactive mesothelial cells in body cavity fluids. Diagn Cytopathol 2005;32:151-155
6. Miettinen M, Kovatich A: HBME-1, a monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft-tissue and bone tumors. Appl Immunohistochem 1995;3:115-122
7. Gümürdülü D, Zeren EH, Cagle PT, Gümü rdülü D, Zeren EH, Cagle PT, Kayasel uk F, Alparslan N, Kocabas A, Tuncer I: Specificity of MOC-31 and HBME-1 immunohistochemistry in the differential diagnosis of adenocarcinoma and malignant mesothelioma: A study on environmental malignant mesothelioma cases from Turkish villages. Pathol Oncol Res 2002;8: 188-193
8. Passebosc-Faure K, Li G, Lambert C, Cottier M, GentilPerret A, Fournel P, Pérol M, Genin C: Evaluation of a panel of molecular markers for the diagnosis of malignant serous effusions. CKn Cancer Res 2005;11:6862-6867
9. Afify AM, Stern R, Mchael CW: Differentiation of mesothelioma from adenocarcinoma in serous effusions: The role of hyaluronic acid and CD44 localization. Diagn Cytopathol 2005;32:145-150
10. Ordonez NC: The immunohistochemical diagnosis of mesothelioma: A comparative study of epithelioid mesothelioma and lung adenocarcinoma. AmJ Surg Pathol 2003;27:1031-1051
11. Yaziji H, Battifora H, Barry TS, Hwang HC, Bacchi CE, Mcintosh MW, Kussick SJ, Gown AM: Evaluation of 12 antibodies for distinguishing epithelioid mesothelioma from adenocarcinoma: Identification of a three-antibody immunohistochemical panel with maximal sensitivity and specificity. Mod Pathol 2006;19:514-523
12. Gerhard M, Juhl H, Kalthoff H, Schreiber HW, Wagener C, Neumaier M: Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction. J Clin Oncol 1994;12: 725-729
13. Mori M, Mimori K, Ueo H, Tsuji K, Shiraishi T, Barnard GF, Sugimachi K, Akiyoshi T: Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription polymerase chain reaction in patients with gastrointestinal or breast carcinomas. J Clin Oncol 1998; 16:128-132
14. Lozano MD, Panizo A, Toledo GR, SoIaJJ, Pardo-Mindân J: Immunocytochemistry in the differential diagnosis of serous effusions: A comparative evaluation of eight monoclonal antibodies in Papanicolaou stained smears. Cancer 2001;93:68-72
15. Yu CJ, Shew JY, Liaw YS, Kuo SH, Luh KT, Yang PC: Application of mucin quantitative competitive reverse transcription polymerase chain reaction in assisting the diagnosis of malignant pleural effusion. Am J Respir Crit Care Med 2001 ;164: 1312-1318
16. Grünewald K, HaunM, Fiegl M, UrbanekM, Müller-Holzner E, Massoner A, Riha K, Propst A, Marth C, Gastl G Mammaglobin expression in gynecologic malignancies and malignant effusions detected by nested reverse transcriptase-polymerase chain reaction. Lab Invest 2002;82:1147-1153
17. Vicidomini G, Santini M, Fiorello A, Parascandolo V, Calabro B, Pastore V: Intraoperative pleural lavage: Is it a valid prognostic factor in lung cancer? Ann Thorac Surg 2005;79:254257
18. Saintigny P, Coulon S, Kambouchner M, Ricci S, Nlarunot E, Danel C, Breau JL, Bernaudin JF Real-time RT-PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinoma. Int J Cancer 2005;115:777-782
19. Dong Q, Huang J Zhou Y, Li L, Bao G, Feng J, Sha H: Hematogenous dissemination of lung cancer cells during surgery: Quantitative detection by flow cytometry and prognostic significance. Lung Cancer 2002;37:293-301
20. Hermans P, Hutter RV, Sobin LH, Wittekind C: International Union Against Cancer: Classification of isolated tumor cells and micrometastasis. Cancer 1999;86:2668-2673